Sartorius Stedim Biotech SA/  FR0013154002  /

Euronext - Paris
6/12/2024  5:35:13 PM Chg. -7.50 Volume Bid5:40:00 PM Ask5:40:00 PM Market Capitalization Dividend Y. P/E Ratio
182.20EUR -3.95% 98,019
Turnover: 18.04 mill.
181.50Bid Size: 108 185.50Ask Size: 100 16.8 bill.EUR 0.38% 54.23

Fundamentals

  FY 2023 Growth (1Y)
Per Share  
Earnings per Share: 3.36 EUR -64.67%
EPS Diluted: - EUR -64.67%
Revenues per Share: 30.11 EUR -20.53%
Book Value per Share: 28.62 EUR 7.70%
Cash Flow per Share: 8.10 EUR 21.90%
Dividend per Share: 0.69 EUR -52.08%
Total in mill.  
Revenues: 2,775.50 EUR -20.53%
Net Income: 309.70 EUR -64.65%
Operating Cash Flow: 746.40 EUR -
Cash and Cash Equivalents: 116.60 EUR -

Valuation Ratios

  Current Latest FY*
P/E Ratio: 54.23 71.28
P/S Ratio: 6.05 7.95
P/BV ratio: 6.37 8.37
P/CF Ratio: 22.50 29.58
PEG: -0.84 -1.10
Earnings Yield: 1.84% 1.40%
Dividend Yield: 0.38% 0.29%
Market Capitalization  
Market Capitalization: 16.8 bill. EUR 22.08 bill. EUR
Free Float Market Cap.: - EUR - EUR
Market Cap. / Employee: 1.58 mill. EUR 2.07 mill. EUR
Shares Outstanding: 92.18 mill.  
 

Profitability

Gross Profit Margin: 44.44%
EBIT Margin: 16.17%
Net Profit Margin: 11.16%
Return on Equity: 11.74%
Return on Assets: 4.00%

Financial Strength

Liquidity I / Cash Ratio: 12.44%
Liquidity II / Quick Ratio: 43.77%
Liquidity III / Current Ratio: 150.98%
Debt / Equity Ratio: 193.41%
Dynam. Debt / Equity Ratio: 683.55%

Efficiency

Employees: 10,662
Personal Expenses / Employee: - EUR
Revenues / Employee: 260,317.01 EUR
Net Income / Employee: 29,047.08 EUR
Total Assets / Employee: 725,933.22 EUR
 
* Fiscal Year End: 12/31/2023
Accounting Standard: IFRS
Currency: EUR